Biotek-snakken — Marts 2022
-
-
Se eventuelt med her i relation til fald sektorens selskaber: https://www.youtube.com/watch?v=wq7lpKv7h4g&t=51s
-
Bioporto vil hente stort millionbeløb i aktieemission
Eksisterende aktionærer får fortegningsret, når Bioporto skal hente op mod 100 mio. kr. i en aktieemmission.
(medwatch.dk)
-
Bioporto venter driftsunderskud på 95-100 mio. kr. i 2022 - NY2 https://proinvestor.com/investornyt/791618/bioporto-venter-driftsunderskud-pa-95-100-mio-kr-i-2022-ny2
-
Evaxion Biotech Completes Recruitment for Phase 1/2a Clinical Trial for EVX-02 https://evaxion-biotech.com/news-and-events/press-releases/news-details/2022/Evaxion-Biotech-Completes-Recruitment-for-Phase-12a-Clinical-Trial-for-EVX-02/default.aspx
-
Bavarian/Jefferies: Sænker kursmål til 290 kr. fra 415 kr. https://proinvestor.com/investornyt/792077/bavarian-jefferies-saenker-kursmal-til-290-kr-fra-415-kr
-
HK Privat stævner Novozymes for at underbetale kvinder https://nyheder.tv2.dk/samfund/2022-03-08-hk-privat-staevner-novozymes-for-at-underbetale-kvinder?fbclid=IwAR1J-0SjvFOSFcV2xSbgCXTEY6Ym3KOGa-iae_aaL7eMcZZP5dr-XjwRgns
-
Genmab Announces U.S. Food and Drug Administration Granted Orphan-Drug Designation to Epcoritamab (DuoBody
-CD3xCD20) in Follic https://proinvestor.com/investornyt/792186/genmab-announces-us-food-and-drug-administration-granted-orphan-drug-designation-to-epcoritamab-duobody-cd3xcd20-in-follic
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind